| RM9 | Name: | (1aR,7bS)-5-fluoro-2-hydroxy-1,1a,2,7b-tetrahydrocyclopropa[c][1,2]benzoxaborinine-4-carboxylic acid | Formula: | C10 H8 B F O4 | SMILES: | B1(Oc3c(C(O)=O)c(ccc3C2C1C2)F)O | InChi: | InChI=1S/C10H8BFO4/c12-7-2-1-4-5-3-6(5)11(15)16-9(4)8(7)10(13)14/h1-2,5-6,15H,3H2,(H,13,14)/t5-,6-/m1/s1 | Definition date: | 2019-11-24 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | (1aR,7bS)-5-fluoro-2-hydroxy-1,1a,2,7b-tetrahydrocyclopropa[c][1,2]benzoxaborinine-4-carboxylic acid |
|
| PMS | Name: | phenylmethanesulfonic acid | Formula: | C7 H8 O3 S | SMILES: | O=S(=O)(O)Cc1ccccc1 | InChi: | InChI=1S/C7H8O3S/c8-11(9,10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,8,9,10) | Definition date: | 2009-08-24 | Last modified: | 2024-09-27 | Identifier: | phenylmethanesulfonic acid |
|
| VPF | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1S)-2-phenyl-1-phosphonoethyl]-L-prolinamide | Formula: | C22 H32 N3 O8 P | SMILES: | O=C(NC(Cc1ccccc1)P(=O)(O)O)C2N(C(=O)C(NC(=O)CCC(=O)O)C(C)C)CCC2 | InChi: | InChI=1S/C22H32N3O8P/c1-14(2)20(23-17(26)10-11-19(27)28)22(30)25-12-6-9-16(25)21(29)24-18(34(31,32)33)13-15-7-4-3-5-8-15/h3-5,7-8,14,16,18,20H,6,9-13H2,1-2H3,(H,23,26)(H,24,29)(H,27,28)(H2,31,32,33)/t16-,18-,20-/m0/s1 | Definition date: | 2012-02-10 | Last modified: | 2024-09-27 | Release date: | 2013-01-18 | Identifier: | N-(3-carboxypropanoyl)-L-valyl-N-[(1S)-2-phenyl-1-phosphonoethyl]-L-prolinamide |
|
| OCS | Name: | CYSTEINESULFONIC ACID | Formula: | C3 H7 N O5 S | SMILES: | O=S(=O)(O)CC(C(=O)O)N | InChi: | InChI=1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/t2-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 3-sulfo-L-alanine |
|
| LW6 | Name: | 1H-indole-4-carbaldehyde | Formula: | C9 H7 N O | SMILES: | O=Cc1cccc2[NH]ccc12 | InChi: | InChI=1S/C9H7NO/c11-6-7-2-1-3-9-8(7)4-5-10-9/h1-6,10H | Definition date: | 2023-08-15 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | 1H-indole-4-carbaldehyde |
|
| OCT | Name: | N-OCTANE | Formula: | C8 H18 | SMILES: | CCCCCCCC | InChi: | InChI=1S/C8H18/c1-3-5-7-8-6-4-2/h3-8H2,1-2H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | octane |
|
| MP4 | Name: | (2S)-amino(3,5-dihydroxy-4-methylphenyl)ethanoic acid | Formula: | C9 H11 N O4 | SMILES: | O=C(O)C(c1cc(O)c(c(O)c1)C)N | InChi: | InChI=1S/C9H11NO4/c1-4-6(11)2-5(3-7(4)12)8(10)9(13)14/h2-3,8,11-12H,10H2,1H3,(H,13,14)/t8-/m0/s1 | Definition date: | 2012-02-10 | Last modified: | 2024-09-27 | Identifier: | (2S)-amino(3,5-dihydroxy-4-methylphenyl)ethanoic acid |
|
| NYB | Name: | N-METHYL-S-[(1R)-1-METHYLPROPYL]-L-CYSTEINE | Formula: | C8 H17 N O2 S | SMILES: | O=C(O)C(NC)CSC(CC)C | InChi: | InChI=1S/C8H17NO2S/c1-4-6(2)12-5-7(9-3)8(10)11/h6-7,9H,4-5H2,1-3H3,(H,10,11)/t6-,7+/m1/s1 | Definition date: | 2010-07-14 | Last modified: | 2024-09-27 | Identifier: | N-methyl-S-[(1R)-1-methylpropyl]-L-cysteine |
|
| T8J | Name: | 1-[4-(thiophene-2-carbonyl)piperazin-1-yl]ethan-1-one | Formula: | C11 H14 N2 O2 S | SMILES: | N1(CCN(CC1)C(C)=O)C(c2cccs2)=O | InChi: | InChI=1S/C11H14N2O2S/c1-9(14)12-4-6-13(7-5-12)11(15)10-3-2-8-16-10/h2-3,8H,4-7H2,1H3 | Definition date: | 2020-03-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | 1-[4-(thiophene-2-carbonyl)piperazin-1-yl]ethan-1-one |
|
| LW8 | Name: | trimethyl-[(2S)-1-oxidanyl-1-oxidanylidene-3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)propan-2-yl]azanium | Formula: | C9 H16 N3 O2 S | SMILES: | C[N+](C)(C)[CH](CC1=CNC(=S)N1)C(O)=O | InChi: | InChI=1S/C9H15N3O2S/c1-12(2,3)7(8(13)14)4-6-5-10-9(15)11-6/h5,7H,4H2,1-3H3,(H2-,10,11,13,14,15)/p+1/t7-/m0/s1 | Definition date: | 2019-08-30 | Last modified: | 2024-09-27 | Release date: | 2020-08-26 | Identifier: | trimethyl-[(2~{S})-1-oxidanyl-1-oxidanylidene-3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)propan-2-yl]azanium |
|
| NIN | Name: | DINITROPHENYLENE | Formula: | C6 H4 N2 O4 | SMILES: | O=[N+]([O-])c1cccc([N+]([O-])=O)c1 | InChi: | InChI=1S/C6H4N2O4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H | Definition date: | 2001-01-26 | Last modified: | 2024-09-27 | Identifier: | 1,3-dinitrobenzene |
|
| VPI | Name: | [(3~{R})-4-[[3-(6-acetamidohexylamino)-3-oxidanylidene-propyl]amino]-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-butyl] dihydrogen phosphate | Formula: | C17 H34 N3 O8 P | SMILES: | CC(=O)NCCCCCCNC(=O)CCNC(=O)[CH](O)C(C)(C)CO[P](O)(O)=O | InChi: | InChI=1S/C17H34N3O8P/c1-13(21)18-9-6-4-5-7-10-19-14(22)8-11-20-16(24)15(23)17(2,3)12-28-29(25,26)27/h15,23H,4-12H2,1-3H3,(H,18,21)(H,19,22)(H,20,24)(H2,25,26,27)/t15-/m0/s1 | Definition date: | 2023-08-02 | Last modified: | 2024-09-27 | Release date: | 2023-11-01 | Identifier: | [(3~{R})-4-[[3-(6-acetamidohexylamino)-3-oxidanylidene-propyl]amino]-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-butyl] dihydrogen phosphate |
|
| OSE | Name: | O-SULFO-L-SERINE | Formula: | C3 H7 N O6 S | SMILES: | O=S(=O)(O)OCC(C(=O)O)N | InChi: | InChI=1S/C3H7NO6S/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/t2-/m0/s1 | Definition date: | 2005-02-24 | Last modified: | 2024-09-27 | Identifier: | O-sulfo-L-serine |
|
| R8L | Name: | (E)-3-[2-[(2R,3S)-3-[(1R)-1-aminocarbonyloxypropyl]oxiran-2-yl]phenyl]prop-2-enoic acid | Formula: | C15 H17 N O5 | SMILES: | CC[CH](OC(N)=O)[CH]1O[CH]1c2ccccc2C=CC(O)=O | InChi: | InChI=1S/C15H17NO5/c1-2-11(20-15(16)19)14-13(21-14)10-6-4-3-5-9(10)7-8-12(17)18/h3-8,11,13-14H,2H2,1H3,(H2,16,19)(H,17,18)/b8-7+/t11-,13-,14+/m1/s1 | Definition date: | 2023-09-05 | Last modified: | 2024-09-27 | Release date: | 2024-06-12 | Identifier: | (~{E})-3-[2-[(2~{R},3~{S})-3-[(1~{R})-1-aminocarbonyloxypropyl]oxiran-2-yl]phenyl]prop-2-enoic acid |
|
| RMD | Name: | [(1,2,5,6-eta)-cyclooctane-1,2,5,6-tetrayl]{(1,2,3,4,5-eta)-1-[2-(2,5-dioxopyrrolidin-1-yl)ethyl]cyclopentadienyl}rhodium | Formula: | C19 H24 N O2 Rh | SMILES: | O=C1N(C(=O)CC1)CCC2%10C7C8C9C2[Rh]789%10456C3CCC6C5CCC34 | InChi: | InChI=1S/C11H12NO2.C8H12.Rh/c13-10-5-6-11(14)12(10)8-7-9-3-1-2-4-9 | Definition date: | 2013-10-18 | Last modified: | 2024-09-27 | Release date: | 2014-04-09 | Identifier: | [(1,2,5,6-eta)-cyclooctane-1,2,5,6-tetrayl]{(1,2,3,4,5-eta)-1-[2-(2,5-dioxopyrrolidin-1-yl)ethyl]cyclopentadienyl}rhodium |
|
| P7T | Name: | 4-[(2~{R},6~{S})-2,6-dimethylmorpholin-4-yl]sulfonylbenzaldehyde | Formula: | C13 H17 N O4 S | SMILES: | C[CH]1CN(C[CH](C)O1)[S](=O)(=O)c2ccc(C=O)cc2 | InChi: | InChI=1S/C13H17NO4S/c1-10-7-14(8-11(2)18-10)19(16,17)13-5-3-12(9-15)4-6-13/h3-6,9-11H,7-8H2,1-2H3/t10-,11+ | Definition date: | 2020-04-16 | Last modified: | 2024-09-27 | Release date: | 2020-09-23 | Identifier: | 4-[(2~{R},6~{S})-2,6-dimethylmorpholin-4-yl]sulfonylbenzaldehyde |
|
| T8L | Name: | Thio-phosohothreonine | Formula: | C4 H10 N O5 P S | SMILES: | C[CH](O[P](O)(S)=O)[CH](N)C(O)=O | InChi: | InChI=1S/C4H10NO5PS/c1-2(3(5)4(6)7)10-11(8,9)12/h2-3H,5H2,1H3,(H,6,7)(H2,8,9,12)/t2-,3+/m1/s1 | Definition date: | 2017-12-22 | Last modified: | 2024-09-27 | Release date: | 2018-01-03 | Identifier: | (2~{S},3~{R})-2-azanyl-3-[oxidanyl(sulfanyl)phosphoryl]oxy-butanoic acid |
|
| OCX | Name: | (5E,11E,14E)-8-oxoicosa-5,9,11,14-tetraenoic acid | Formula: | C20 H30 O3 | SMILES: | O=C(C=CC=CC/C=C/CCCCC)C/C=C/CCCC(=O)O | InChi: | InChI=1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-13-16-19(21)17-14-11-12-15-18-20(22)23/h6-7,9-11,13-14,16H,2-5,8,12,15,17-18H2,1H3,(H,22,23)/b7-6+,10-9+,14-11+,16-13? | Synonyms: | 8-oxo-eicosatetraenoic acid | Definition date: | 2008-03-17 | Last modified: | 2024-09-27 | Identifier: | (5E,9E,11E,14E)-8-oxoicosa-5,9,11,14-tetraenoic acid |
|
| T8M | Name: | 1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one | Formula: | C11 H16 N2 O S | SMILES: | N1(CCN(CC1)C(C)=O)Cc2cccs2 | InChi: | InChI=1S/C11H16N2OS/c1-10(14)13-6-4-12(5-7-13)9-11-3-2-8-15-11/h2-3,8H,4-7,9H2,1H3 | Definition date: | 2020-03-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | 1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one |
|
| P7U | Name: | {(2S)-4-[(7P)-7-(8-chloronaphthalen-1-yl)-8-fluoro-2-{[(4R,7as)-tetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}pyrido[4,3-d]pyrimidin-4-yl]-1-[(3S)-2,2,3-trihydroxybutanoyl]piperazin-2-yl}acetonitrile | Formula: | C35 H37 Cl F N7 O5 | SMILES: | CC(O)C(O)(O)C(=O)N1CCN(CC1CC#N)c1nc(nc2c(F)c(ncc21)c1cccc2cccc(Cl)c21)OCC12CCCN2CCC1 | InChi: | InChI=1S/C35H37ClFN7O5/c1-21(45)35(47,48)32(46)44-17-16-42(19-23(44)10-13-38)31-25-18-39-29(24-8-2-6-22-7-3-9-26(36)27(22)24)28(37)30(25)40-33(41-31)49-20-34-11-4-14-43(34)15-5-12-34/h2-3,6-9,18,21,23,45,47-48H,4-5,10-12,14-17,19-20H2,1H3/t21-,23-/m0/s1 | Definition date: | 2022-05-25 | Last modified: | 2024-09-27 | Release date: | 2022-08-31 | Identifier: | {(2S)-4-[(7P)-7-(8-chloronaphthalen-1-yl)-8-fluoro-2-{[(4R,7as)-tetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}pyrido[4,3-d]pyrimidin-4-yl]-1-[(3S)-2,2,3-trihydroxybutanoyl]piperazin-2-yl}acetonitrile |
|
| MP8 | Name: | (4R)-4-methyl-L-proline | Formula: | C6 H11 N O2 | SMILES: | O=C(O)C1NCC(C)C1 | InChi: | InChI=1S/C6H11NO2/c1-4-2-5(6(8)9)7-3-4/h4-5,7H,2-3H2,1H3,(H,8,9)/t4-,5+/m1/s1 | Definition date: | 2009-08-18 | Last modified: | 2024-09-27 | Identifier: | (4R)-4-methyl-L-proline |
|
| TOX | Name: | 1-hydroperoxy-L-tryptophan | Formula: | C11 H12 N2 O4 | SMILES: | O=C(O)C(N)Cc2c1ccccc1n(OO)c2 | InChi: | InChI=1S/C11H12N2O4/c12-9(11(14)15)5-7-6-13(17-16)10-4-2-1-3-8(7)10/h1-4,6,9,16H,5,12H2,(H,14,15)/t9-/m0/s1 | Definition date: | 2006-08-21 | Last modified: | 2024-09-27 | Identifier: | 1-hydroperoxy-L-tryptophan |
|
| OCY | Name: | HYDROXYETHYLCYSTEINE | Formula: | C5 H11 N O3 S | SMILES: | O=C(O)C(N)CSCCO | InChi: | InChI=1S/C5H11NO3S/c6-4(5(8)9)3-10-2-1-7/h4,7H,1-3,6H2,(H,8,9)/t4-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | S-(2-hydroxyethyl)-L-cysteine |
|
| UTL | Name: | (1R,2S)-2-{[N-({2-[(4-fluorophenyl)sulfanyl]-2-methylpropoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C24 H36 F N3 O8 S2 | SMILES: | CC(C)CC(NC(=O)OCC(C)(C)Sc1ccc(F)cc1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C24H36FN3O8S2/c1-14(2)11-18(28-23(32)36-13-24(3,4)37-17-7-5-16(25)6-8-17)21(30)27-19(22(31)38(33,34)35)12-15-9-10-26-20(15)29/h5-8,14-15,18-19,22,31H,9-13H2,1-4H3,(H,26,29)(H,27,30)(H,28,32)(H,33,34,35)/t15-,18-,19-,22+/m0/s1 | Definition date: | 2022-08-25 | Last modified: | 2024-09-27 | Release date: | 2022-09-07 | Identifier: | (1R,2S)-2-{[N-({2-[(4-fluorophenyl)sulfanyl]-2-methylpropoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
| NYG | Name: | [(4Z)-2-[(1S)-1,3-DIAMINO-3-OXOPROPYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | Formula: | C15 H16 N4 O5 | SMILES: | O=C(N)CC(N)C1=N/C(C(=O)N1CC(=O)O)=Cc2ccc(O)cc2 | InChi: | InChI=1S/C15H16N4O5/c16-10(6-12(17)21)14-18-11(15(24)19(14)7-13(22)23)5-8-1-3-9(20)4-2-8/h1-5,10,20H,6-7,16H2,(H2,17,21)(H,22,23)/b11-5-/t10-/m0/s1 | Synonyms: | CHROMOPHORE (ASN-TYR-GLY) | Definition date: | 2007-01-19 | Last modified: | 2024-09-27 | Identifier: | {(4Z)-2-[(1S)-1,3-diamino-3-oxopropyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|